Adam Pearson plays a pivotal role in shaping corporate strategy, spearheading initiatives in business planning, the development and execution of Primary Focus strategies, business partnerships, Rx+ business creation, Patient Centricity, and sustainability efforts.

Adam joined Yamanouchi (now Astellas) in 2004 after his tenure at Boston Consulting Group. Throughout his career, he has held several prominent positions, including Regional Senior Vice President (SVP) North Europe at Astellas Pharma Europe Ltd. and General Manager for the United Kingdom at Astellas Pharma Ltd. In April 2020, he was appointed as SVP of Corporate Planning at Astellas Pharma Inc., and in April 2023, he took on the role of CStO.

With over 20 years of experience in strategic and operational roles within the life sciences sector, Adam has held key leadership roles across various countries, regions, divisions, and functions. He is also a strong advocate for patient centricity, drawing from his personal experiences as a patient.

Education: MBA, Stanford Graduate School of Business; BA, Philosophy, Politics and Economics, Oxford University